183
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Investigation of the Retinal and Optic Disc Microvascularization in Polycystic Ovary Syndrome: An Optical Coherence Tomography Angiography Study

, MD, , MD & , MD
Pages 92-96 | Received 03 Jun 2021, Accepted 22 Sep 2021, Published online: 12 Oct 2021

References

  • Zhu YH, Qu F. Towards a multidimensional scientific approach to improve clinical practices for infertility treatment. J Zhejiang Univ Sci B. 2018;19(11):815–817. doi:10.1631/jzus.B1801014.
  • Teberik K, Saglam H, Basbug A, Karaaslan M, Kaya M, Mehmet Ali Sungur. Assessment of central corneal thickness, intraocular pressure and retinal nerve fiber layer thickness at women with polycystic ovary syndrome. Konuralp Tıp Dergisi. 2017;9(2):65–68.doi:10.18521/ktd.298734.
  • Baser G, Yildiz N, Calan M. Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res. 2017;42(5):661–665. doi:10.1080/02713683.2016.1233985.
  • Yuksel B, Ozturk I, Seven A, et al. Tear function alterations in patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2015;19:3556–3562.
  • Asfuroğlu Y, Ö K, Asfuroğlu M, Baser E. Association between dry eye and polycystic ovary syndrome: subclinical inflammation may be part of the process. Eye Contact Lens. 2021 Jan 1;47(1):27–31. doi:10.1097/ICL.0000000000000716.
  • Gonen T, Celik C, Oznur M, et al. Tear osmolarity and ocular surface changes in patients with polycystic ovary syndrome. Curr Eye Res. 2013 Jun;38(6):621–625. doi:10.3109/02713683.2012.749917.
  • Özcan Dağ Z, Örnek N, Örnek K. Corneal endothelial cell density and morphology in patients with polycystic ovary syndrome. Turkiye Klinikleri J Ophthalmol. 2018;27(2):129–134. doi:10.5336/ophthal.2017-56851.
  • Witmer MT, Klufas MA, Kiss S. Polycystic ovary syndrome and central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2015;46(6):684–686. doi:10.3928/23258160-20150610-16.
  • Açmaz G, Ataş M, Gülhan A, Açmaz B, Ataş F, Aksoy H. Evaluation of the macula, retinal nerve fiber layer, and choroid thickness in women with polycystic ovary syndrome using spectral-domain optical coherence tomography. Reprod Sci. 2014;21(8):1044–1049. doi:10.1177/1933719114522523.
  • Demir M, Guven D, Koc A, Ozdemir S, Can E. Retinal nerve fiber layer thickness in women with polycystic ovary syndrome. J Ophthalmol. 2013;2013:752186. doi:10.1155/2013/752186.
  • de Souza-Júnior JE, Garcia CA, Soares EM, Maranhão TM, Lemos TM, Azevedo GD. Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography. J Ophthalmol. 2015;2015:193078.
  • Kaya MK, Turgut B, Demir T, Celiker U, Gurates B. A case of Vogt-Koyanagi-Harada disease associated with polycystic ovary syndrome. J Clin Med Res. 2011;3:93–95.
  • Karaca Adıyeke S, Karaca I, Yıldırım S, Adıyeke M, Uyar I, Türe G. Anterior segment findings in women with polycystic ovary syndrome. Turk J Ophthalmol. 2017;47:24–27. doi:10.4274/tjo.73659.
  • Karaca Adiyeke S, Karaca I, Adiyeke M, Yildirim S, Ture G. Evaluation of the fundus findings in women with polycystic ovary syndrome. Ret Vit. 2017;26:117–121.
  • Ulaş F, Ü D, Duran B, Keleş A, Ağca S, Eşitken C. Evaluation of polycystic ovary syndrome patients using optical coherence tomography. Turkiye Klinikleri J Ophthalmol. 2015;24(2):76–83. doi:10.5336/ophthal.2014-41969.
  • Akarsu Acar OP, Cengiz H, Onur IU, Iliman DE, Zirtiloglu S, Yigit FU. Assessment of the retinal and choroidal microvascularization in polycystic ovary syndrome: an optical coherence tomography angiography study. Int Ophthalmol. 2021;41:2339–2346. doi:10.1007/s10792-021-01787-0.
  • Lim HB, Lee MW, Park JH, Kim K, Jo YJ, Kim JY. Changes in ganglion cell-inner plexiform layer thickness and retinal microvasculature in hypertension: an optical coherence tomography angiography study. Am J Ophthalmol. 2019;199:167–176. doi:10.1016/j.ajo.2018.11.016.
  • Al-Sheikh M, Phasukkijwatana N, Dolz-Marco R, et al. OCT angiography of the retinal microvasculature and the choriocapillaris in myopic eyes. Invest Ophthalmol Vis Sci. 2017;58(4):2063–2069. doi:10.1167/iovs.16-21289.
  • Nuzzi R, Scalabrin S, Becco A, Panzica G. Gonadal hormones and retinal disorders: a review. Front Endocrinol. 2018;9:66. doi:10.3389/fendo.2018.00066.
  • Toker E, Yenice O, Akpinar I, Aribal E, Kazakoglu H. The influence of sex hormones on ocular blood flow in women. Acta Ophthalmol Scand. 2003;81(6):617–624. doi:10.1111/j.1395-3907.2003.00160.x.
  • Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219–227. doi:10.1530/REP-14-0435.
  • Örnek N, İnal M, ÖB T, Özcan-Dağ Z, Örnek K. Ocular blood flow in polycystic ovary syndrome. J Obstet Gynaecol Res. 2015;41(7):1080–1086. doi:10.1111/jog.12673.
  • Movsas TZ, Wong KY, Ober MD, Sigler R, Lei ZM, Muthusamy A. Confirmation of luteinizing hormone (LH) in living human vitreous and the effect of LH receptor reduction on murine electroretinogram. Neuroscience. 2018;385:1–10. doi:10.1016/j.neuroscience.2018.05.049.
  • Movsas TZ, Sigler R, Muthusamy A. Vitreous levels of luteinizing hormone and VEGF are strongly correlated in healthy mammalian eyes. Curr Eye Res. 2018;43(8):1041–1044. doi:10.1080/02713683.2018.1467932.
  • Basu BR, Chowdhury O, Saha SK. Possible link between stress-related factors and altered body composition in women with polycystic ovarian syndrome. J Hum Reprod Sci. 2018;11(1):10–18. doi:10.4103/jhrs.JHRS_78_17.
  • Mansour AM, Koaik M, Lima LH, et al. Physiologic and psychologic risk factors in central serous chorioretinopathy. Ophthalmol Retina. 2017;1(6):497–507. doi:10.1016/j.oret.2017.02.009.
  • Lupidi M, Fruttini D, Eandi CM, et al. Chronic neovascular central serous chorioretinopathy: a stress/rest optical coherence tomography angiography study. Am J Ophthalmol. 2020;211:63–75. doi:10.1016/j.ajo.2019.10.033.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.